Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 2
1(33.3%)
3Total
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02166788Phase 3Completed

Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma

Role: collaborator

NCT03091764Completed

Evaluation of a Patient-Reported Symptom Index for NMIBC

Role: collaborator

NCT04354818Unknown

Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

Role: collaborator

NCT00096408Phase 3Completed

Laparoscopic Approach to Cancer of the Endometrium

Role: collaborator

NCT00193869Phase 2Completed

SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).

Role: collaborator

All 5 trials loaded